Evogen's Cognizance Biomarkers Presents Data Showing Its Proteomic Biomarkers Have the Potential to Monitor Seizure Burden to Aid in Epilepsy Patient Management

Tuesday, May 28, 2019 General News
Email Print This Page Comment bookmark
Font : A-A+

--Data Presented at 2019 Antiepileptic Drug and Device Trials XV Conference Supports Further Development of a Blood-Based Test to Accurately Monitor Seizure Burden--

Contacts

Evogen/Cognizance Biomarkers:                 

Media:

Richard St. Clair

Barbara Lindheim 

rich@cognizancebio.com

blindheim@bllbiopartners.com

917.355.9234



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store